A case of treatment of multidrug-resistant intracranial Klebsiella pneumoniae infection by multichannel colistin sulfate.

Abstract

The management of severe neurologic infections due to multidrug-resistant (MDR) Klebsiella pneumoniae infection remains a challenge. Limited antibiotic treatment regimens make treatment of severe MDR K. pneumoniae infection more difficult. We describe a patient who developed severe meningitis and ventriculitis after craniotomy caused by MDR K. pneumoniae and was effectively treated with the administration of multichannel applications (intravenous, intrathecal and aerosol inhalation) of colistin sulfate. This case provides clinical evidence that the intrathecal, intravenous and aerosol inhalation of colistin sulfate by multichannel application can be a last resort in refractory intracranial infection by MDR K. pneumoniae.

• Authors: Xiaona Li, Xin Guo, Yangfeng Liu, Rong Chen, Chen Ma, Xiaogang Kang, Fang Yang, Wen Li, Wen Jiang
• Journal: Future microbiology (Future Microbiol) Vol. 18 Pg. 547-552 (06 2023) ISSN: 1746-0921 [Electronic] England
• PMID: 37314362 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Colistin
• Anti-Bacterial Agents

Topics

• Humans
• Colistin (therapeutic use, pharmacology)
• Klebsiella pneumoniae
• Klebsiella Infections (drug therapy)
• Drug Resistance, Multiple, Bacterial
• Anti-Bacterial Agents (pharmacology)
• Microbial Sensitivity Tests